CD38 (Dog) Inhibitor Screening Assay Kit (Hydrolase Activity)

Catalog #
78108
$765 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Dog CD38 Inhibitor Screening Assay Kit (Hydrolase Activity) is designed to measure the glycohydrolase activity of canine CD38 for screening and profiling applications. 

Need us to run inhibitor screens or profile your compounds against CD38 (Dog) (Hydrolase Activity)? Check out our Immunotherapy Biochemical Screening Services.

 

Synonyms
ADP-Ribosyl Cyclase screening kit, Cluster Of Differentiation 38 assay kit, CD38 molecule inhibition
Product Info
Storage and Usage
Citations
Assay Kit Format
Fluorogenic
Species
Dog
Supplied As
The CD38 assay kit comes in a convenient 96-well format, with recombinant dog CD38 enzyme, its substrate N6-etheno-NAD (ε-NAD), and CD38 assay buffer. In addition, the kit includes the CD38 inhibitor apigenin for use as a control inhibitor.
Materials Required But Not Supplied

Adjustable micropipettor and sterile tips
Fluorescent microplate reader
Rotating or rocker platform

Format
Catalog Component Amount Storage
100955 CD38 (Dog) 1 µg -80°C


Avoid
multiple
freeze/
thaw
cycles!
  4x CD38 hydrolase buffer 4 ml -20°C
  CD38 substrate
(ε-NAD)
50 µl -20°C
  Apigenin (50 mM in DMSO) 10 µl -20°C
79685 Black 96-well plate 1 Room
Temp
 
Background

CD38, a differentiation antigen of B lymphocytes, is a type II integral membrane protein that functions as an ADP-ribosyl cyclase and nicotinamide adenine dinucleotide (NAD) glycohydrolase. The major enzymatic activity of CD38 is the hydrolysis of NAD. Through its production of cyclic ADP-ribose, CD38 modulates calcium-mediated signal transduction in various cells, including pancreatic ß cells. CD38 is a prognostic biomarker for acute B lymphoblastic leukemia.

References

Koguma, T., et al. Biochim. Biophys. Acta -- Mol. Cell. Res. 1994. 1223(1): 160-162
Malavasi, F., et al. Physiol. Rev. 2008. 88(3): 841-886